Vaccinia Virus Expression Vectors

References

1. Arita I., Fenner F. 1985; Complication of smallpox vaccination. In Vaccinia Viruses as Vectors for Vaccine Antigens pp 49–60 Edited by Quinnan J. New York: Elsevier;
   [Google Scholar]
2. Ball L. A., Young K. K. Y., Anderson K., Collins P. L., Wertz G. W. 1986; Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant virus vectors. Proceedings of the National Academy of Sciences, U. S. A 83:246–250
   [Google Scholar]
3. Baroudy B. M., Venkatesan S., Moss B. 1982; Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia genome into one uninterrupted polynucleotide chain. Cell 18:315–324
   [Google Scholar]
4. Bennink J. R., Yewdell J. W., Smith G. L., Moller C., Moss B. 1984; Recombinant vaccinia virus primes and stimulates influenza virus haemagglutinin-specific cytotoxic T lymphocytes. Nature, London 311:578–579
   [Google Scholar]
5. Bennink J. R., Yewdell I. W., Smith G. L., Moss B. 1986; Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes. Journal of Virology 57:786–791
   [Google Scholar]
6. Berthelot C., Drillien R., Wittek R. 1985; One hundred base pairs of 5′ flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription. Proceedings of the National Academy of Sciences, U.S.A. 82:2096–2100
   [Google Scholar]
7. Boulter E. A., Appleyard G. 1973; Differences between extracellular and intracellular forms of poxvirus and their implications. Progress in Medical Virology 16:86–108
   [Google Scholar]
8. Boyle D. B., Coupar B. E. H., Both G. W. 1985; Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses. Gene 35:169–177
   [Google Scholar]
9. Buller R. M. L., Smith G. L., Cremer K., Notkins A. L., Moss B. 1985; Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature, London 317:813–815
   [Google Scholar]
10. Chakrabarti S., Brechling K., Moss B. 1985; Vaccinia virus expression vector: co-expression of β- galatosidase provides visual screening of recombinant virus plaques. Molecular and Cellular Biology 5:3403–3409
    [Google Scholar]
11. Chakrabarti S., Robert-Guroff M., Wong-Staal F., Gallo R. C., Moss B. 1986; Expression of HTLV-III envelope gene by recombinant vaccinia virus. Nature, London 320:535–537
    [Google Scholar]
12. Cochran M., Mackett M., Moss B. 1985a; Eukaryotic transient expression system dependent on transcription factors and regulatory DNA sequences of vaccinia virus. Proceedings of the National Academy of Sciences, U. S. A 82:19–23
    [Google Scholar]
13. Cochran M. A., Puckett C., Moss B. 19856; In vitro mutagenesis of the promoter region of a vaccinia virus gene: evidence for tandem early and late regulatory signals. Journal of Virology 54:30–37
    [Google Scholar]
14. Condit R. C., Motyczka M., Spizz G. 1983; Isolation, characterization and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology 128:429–443
    [Google Scholar]
15. Conybeare E. T. 1964 Monthly Bulletin of the Ministry of Health and Public Health Laboratory Service 23:150–159
    [Google Scholar]
16. Cremer K., Mackett M., Wohlenberg C., Notkins A. L., Moss B. 1985; Vaccinia virus recombinants expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228:737–740
    [Google Scholar]
17. Dales S., Pogo B. G. T. 1981; Biology of poxviruses. Virology Monographs 181–109 Edited by Kingsbury D. W., Zur Hausen H. New York: Springer-Verlag;
    [Google Scholar]
18. De La Salle H., Altenburger W., Elkaim R., Dott K., Dieterle A., Drillien R., Cuzenave J. P., Tolstoshev P., Lecocq J. P. 1985; Active γ-carboxylated human factor is expressed using recombinant DNA techniques. Nature, London 316:268–270
    [Google Scholar]
19. Dick G. 1966; Smallpox: a reconsideration of public health policies. Progress in Medical Virology 8:1–29
    [Google Scholar]
20. Drillien R., Spehner D. 1983; Physical mapping of vaccinia virus temperature-sensitive mutations. Virology 131:385–393
    [Google Scholar]
21. Elango N., Prince G. A., Murphy B. R., Venkatesan S., Chanock R. M., Moss B. 1986; Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proceedings of the National Academy of Sciences, U.S.A. 83:1906–1910
    [Google Scholar]
22. Ensinger M. J. 1982; Isolation and genetic characterisation of temperature-sensitive mutants of vaccinia virus WR. Journal of Virology 43:778–790
    [Google Scholar]
23. Ensinger M. J., Rovinsky M. 1983; Marker rescue of temperature sensitive mutations of vaccinia virus WR: correlation of the genetic and physical maps. Journal of Virology 48:419–428
    [Google Scholar]
24. Essani K., Dales S. 1979; Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion. Virology 95:385–394
    [Google Scholar]
25. Fenner F. 1985; Poxviruses. In Virology pp 661–684 Edited by Fields N. B. Knipe D. M., Chanock R. M., Melnick J. L., Roizman B. Shope R. E. New York: Raven Press;
    [Google Scholar]
26. Foglesong P. D. 1985; In vitro transcription of a cloned vaccinia virus gene by a soluble extract prepared from vaccinia virus-infected HeLa cells. Journal of Virology 53:822–826
    [Google Scholar]
27. Franke C. A., Rice C. M., Strauss J. H., Hruby D. E. 1985; Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants. Molecular and Cellular Biology 5:1918–1924
    [Google Scholar]
28. Geshelin P., Berns K. I. 1974; Characterization and localisation of the naturally occurring cross-links in vaccinia virus DNA. Journal of Molecular Biology 88:785–796
    [Google Scholar]
29. Golini F., Kates J. R. 1985; A soluble transcription system derived from purified vaccinia virions. Journal of Virology 53:205–213
    [Google Scholar]
30. Hashizume S., Yoshizawa H., Morita M., Suzuki K. 1985; Properties of attenuated mutant of vaccinia virus LC16m8, derived from Lister strain. In Vaccinia Viruses as Vectors for Vaccine Antigens pp 87–100 Edited by Quinnan J. Amsterdam, New York Oxford: Elsevier;
    [Google Scholar]
31. Hu S., Brussewski J., Smalling R. 1985; Infectious vaccinia virus recombinant that expresses the surface antigen of porcine transmissible gastroenteritis virus (TGEV). In Vaccinia Viruses as Vectors for Vaccine Antigens pp 201–208 Edited by Quinnan J. Amsterdam, New York & Oxford: Elsevier;
    [Google Scholar]
32. Hu S.-K., Kosowski S. G., Dalrymple J. M. 1986; Expression of AIDS virus envelope gene in recombinant vaccinia viruses. Nature, London 320:537–540
    [Google Scholar]
33. Ichihashi Y., Matsumoto S., Dales S. 1971; Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology 46:507–532
    [Google Scholar]
34. Joklik W. K. 1962; The purification of four strains of poxvirus. Virology 18:9–18
    [Google Scholar]
35. Jones L., Ristow S., Yilma T., Moss B. 1986; Accidental human vaccination with vaccinia virus expressing nucleoprotein gene. Nature, London 319:543
    [Google Scholar]
36. Kempe C. H., Fulginiti V., Minimitani M., Shienfield H. 1968; Smallpox vaccination of eczema patients with a strain of attenuated live vaccinia (CV1-78). Pediatrics 42:980–985
    [Google Scholar]
37. Kieny M. P., Lathe R., Drillien R., Spehner D., Skory S., Schmitt D., Wiktor T., Koprowski H., Lecocq J. P. 1984; Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature, London 312:163–166
    [Google Scholar]
38. Kozak M. 1983; Comparison of initiation of protein synthesis in prokaryotes, eukaryotes, and organelles. Microbiological Reviews 47:1–45
    [Google Scholar]
39. Lane J. M., Ruben F. L., Neff J. M., Millar J. D. 1969; Complications of smallpox vaccination, 1968. National surveillance in the United States. New England Journal of Medicine 281:1201–1208
    [Google Scholar]
40. Langford C. J., Edwards S. J., Smith G. L., Mitchell G. F., Moss B., Kemp D. J., Anders R. F. 1986; Anchoring a secreted Plasmodium antigen on the surface of recombinant vaccinia virus infected cells increases its immunogenicity. Molecular and Cellular Biology (in press)
    [Google Scholar]
41. Mackett M., Arrand J. R. 1985; Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340. EMBO Journal 4:3229–3234
    [Google Scholar]
42. Mackett M., Smith G. L., Moss B. 1982; Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proceedings of the National Academy of Sciences, U.S.A. 79:7415–7419
    [Google Scholar]
43. Mackett M., Smith G. L., Moss B. 1984; General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
    [Google Scholar]
44. Mackett M., Yilma T., Rose J., Moss B. 1985a; Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science 227:433–435
    [Google Scholar]
45. Mackett M., Smith G. L., Moss B. 1985b; The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning A Practical Approach pp 191–211 Edited by M D. Glover, Oxford: IRL Press;
    [Google Scholar]
46. Mcmichael A. J., Michie C. A., Gotch F. M., Smith G. L., Moss B. 1986; Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. Journal of General Virology 67:719–726
    [Google Scholar]
47. Morgan C. 1976; Vaccinia virus re-examined: development and release. Virology 73:43–58
    [Google Scholar]
48. Moss B. 1985; Replication of poxviruses. In Virology pp 658–703 Edited by Fields N. B. Knipe D. M., Chanock R. M., Melnick J. L., Roizman B. Shope R. E. New York: Raven Press;
    [Google Scholar]
49. Moss B., Winters W., Cooper J. A. 1981; Deletion of a 9,000 base pair segment of the vaccinia genome that codes for non-essential polypeptides. Journal of Virology 40:387–395
    [Google Scholar]
50. Moss B., Smith G. L., Gerin J. L., Purcell R. H. 1984; Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature, London 311:67–69
    [Google Scholar]
51. Moyer R. W., Rothe C. T. 1980; The white pock mutants of rabbit poxvirus. Spontaneous host range mutants contain deletions. Virology 102:119–132
    [Google Scholar]
52. Nakano E., Panicali D., Paoletti E. 1982; Molecular genetics of vaccinia virus: demonstration of marker rescue. Proceedings of the National Academy of Sciences, U.S.A. 79:1593–1596
    [Google Scholar]
53. Newton S., Mackett M., Appleyard G., Francis M. J., Brown F. 1986; Expression of a foot and mouth disease immunogenic site sequence in vaccinia virus. In Vaccines 86 Edited by Lemer A. R. Chanock R. M. Brown F. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
54. Panicali D., Paoletti E. 1982; Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proceedings of the National Academy of Sciences, U.S.A. 79:4927–4931
    [Google Scholar]
55. Panicali D., Davis S. W., Mercer S. R., Paoletti E. 1981; Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. Journal of Virology 37:1000–1010
    [Google Scholar]
56. Panicali D., Davis S. W., Weinberg R. L., Paoletti E. 1983; Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus haemagglutinin. Proceedings of the National Academy of Sciences, U.S.A. 80:5364–5368
    [Google Scholar]
57. Paoletti E., Lipinskas B. R., Samsanoff C., Mercer S., Panicali D. 1984; Construction oflive vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proceedings of the National Academy of Sciences, U.S.A. 81:193–197
    [Google Scholar]
58. Paoletti E., Perkus M., Piccini A., WOS S. M., Lipinskas B. R., Mercer S. R. 1985; Genetically engineered poxviruses expressing multiple foreign genes. In Vaccines 85 pp 147–150 Edited by Lemer R. A. Chanock R. M. Brown F. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
59. Payne L. G. 1979; Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. Journal of Virology 31:147–155
    [Google Scholar]
60. Payne L. G. 1980; Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. Journal of General Virology 50:89–100
    [Google Scholar]
61. Perkus M. E., Piccini A., Lipinskas B. R., Paoletti E. 1985; Recombinant vaccinia virus: immunization against multiple pathogens. Science 229:981–984
    [Google Scholar]
62. Puckett C., Moss B. 1983; Selective transcription of vaccinia virus genes in template-dependent extracts of infected cells. Cell 35:441–448
    [Google Scholar]
63. Rice C. M., Franke C. A., Strauss J. H., Hruby D. E. 1985; Expression of Sindbis virus structural proteins via recombinant vaccinia virus synthesis, processing and incorporation into mature Sindbis virions. Journal of Virology 56:227–239
    [Google Scholar]
64. Rigby P. W. J. 1983; Cloning vectors derived from animal viruses. Journal of General Virology 64:255–266
    [Google Scholar]
65. Rohrmann G., Moss B. 1985; Transcription of vaccinia virus early genes by a template-dependent soluble extract of purified virions. Journal of Virology 56:349–355
    [Google Scholar]
66. Rosel J., Moss B. 1985; Transcriptional and translational mapping and nucleotide sequence of a vaccinia virus gene encoding the precursor of the major core polypeptide 4b. Journal of Virology 56:830–838
    [Google Scholar]
67. Sam C. K., Dumbell K. R. 1981; Expression of poxvirus DNA in coinfected cells and marker rescue of thermosensitive mutants by subgenomic fragments of DNA. Annales de Virologie 132E:135–150
    [Google Scholar]
68. Small P. A. Jr, Smith G. L., Moss B. 1985; Intranasal vaccination with recombinant vaccinia containing influenza haemagglutinin prevents both influenza virus pneumonia and nasal infection: intradermal vaccination prevents only viral pneumonia. In Vaccinia Viruses as Vectors for Vaccine Antigens pp 175–178 Edited by Quinnan J. Amsterdam, New York & Oxford: Elsevier;
    [Google Scholar]
69. Smith G. L., Moss B. 1983; Infectious poxvirus vectors have capacity for at least 25, 000 base pairs of foreign DNA. Gene 25:21–28
    [Google Scholar]
70. Smith G. L., Moss B. 1984; Vaccinia virus expression vectors: construction, properties and applications. BioTechniques 2:306–312
    [Google Scholar]
71. Smith G. L., Mackett M., Moss B. 1983a; Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature, London 302:490–495
    [Google Scholar]
72. Smith G. L., Murphy B. R., Moss B. 1983b; Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza virus hemagglutinin gene and induces resistance to influenza infection in hamsters. Proceedings of the National Academy of Sciences, U.S.A. 80:7155–7159
    [Google Scholar]
73. Smith G. L., Godson G. N., Nussenzweig V., Nussenzweig R. S., Barnwell J., Moss B. 1984; Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus. Science 224:397–399
    [Google Scholar]
74. Smith G. L., Bennink J. R., Yewdell J. W., Small P. A., Murphy B. R., Moss B. 1985; Vaccinia virus recombinants expressing influenza virus genes. In Options for Control of Influenza pp 375–389 Edited by Kendal A. P. New York: Alan R. Liss;
    [Google Scholar]
75. Smith G. L., Cheng K. C., Moss B. 1986; Vaccinia virus: an expression vector for genes from parasites. Parasitology 92S:109–118
    [Google Scholar]
76. Stephens E. B., Compans R. W., Earl P., Moss B. 1986; Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectors. EMBO Journal 5:237–245
    [Google Scholar]
77. Tagaya I., Amano H., Kitamura T., Komatsu T., Veda Y., Tanaka Y., Uchida N., Kodama H. 1973 International Symposium on Smallpox Vaccines Bilthoven, The Netherlands 19299–307 Basel: S. Karger;
    [Google Scholar]
78. Townsend A. R. M., Mcmichael A. J., Carter N. P., Huddleston J. A., Brownlee G. G. 1984; Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected L cells. Cell 39:13–25
    [Google Scholar]
79. Van Der Noordaa J. 1964; Primary vaccination ofadults with an attenuated strain ofvaccinia virus. The history ofthe second revised strain of vaccinia PhD thesis, University of Leiden; pp 1–4
    [Google Scholar]
80. Vassef A., Mars M., Dru A., Plucienniczak A., Streeck R. E., Beaud G. 1985; Isolation of cu-acting vaccinia virus DNA fragments promoting the expression of herpes simplex virus thymidine kinase by recombinant viruses. Journal of Virology 55:163–172
    [Google Scholar]
81. Venkatesan S., Baroudy B. M., Moss B. 1981; Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene. Cell 25:805–813
    [Google Scholar]
82. Venkatesan S., Gershowitz A., MOSS B. 1982; Complete nucleotide sequence of two adjacent early vaccinia virus genes located within the inverted terminal repetition. Journal of Virology 44:637–646
    [Google Scholar]
83. Villareal L. P., Berg P. 1977; Hybridization in situ of SV40 plaques: detection of recombinant SV40 carrying specific sequences of non-viral DNA. Science 196:183–185
    [Google Scholar]
84. Weir J. P., Moss B. 1983; Nucleotide sequence of the vaccinia virus thymidine kinase gene and the nature of spontaneous frameshift mutations. Journal of Virology 46:530–537
    [Google Scholar]
85. Weir J. P., Moss B. 1984; Regulation of expression and nucleotide sequence of a late vaccinia virus gene. Journal of Virology 51:662–669
    [Google Scholar]
86. Weir J. P., Bajszar G., Moss B. 1982; Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA. Proceedings of the National Academy of Sciences, U. S. A 79:1210–1214
    [Google Scholar]
87. Wertz G., Anderson K., Young K., Ball A. 1985; Expression of the fusion (F) protein of respiratory syncytial virus from vaccinia virus vectors.. Virus Research, supplement 1:31
    [Google Scholar]
88. Wiktor T. J., Macfarlan R. I., Reagan K. J., Dietzschold B., Curtis P. J., Wunner W. H., Kieny M.-P., Lathe R., Lecocq J.-P., Mackett M., Moss B., Koprowski H. 1984; Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proceedings of the National Academy of Sciences, U.S.A. 81:7194–7198
    [Google Scholar]
89. Witter R., Hanaggi M., Hiller G. 1984a; Mapping of a gene coding for a major late structural polypeptide on the vaccinia virus genome. Journal of Virology 49:371–378
    [Google Scholar]
90. Witter R., Richner B., Hiller G. 1984b; Mapping of the genes coding for the major vaccinia core polypeptides. Nucleic Acids Research 12:4835–4848
    [Google Scholar]
91. World Health Organization 1980 The global eradication of smallpox. Final report of the global commission for the certification of smallpox eradication Geneva: World Health Organization;
    [Google Scholar]
92. Yewdell J. W., Bennink J. R., Smith G. I., Moss B. 1985; Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences, U.S.A. 82:1785–1789
    [Google Scholar]